Advanced Medical Isotope (OTCMKTS:RDGL) & Rand Capital (NASDAQ:RAND) Head-To-Head Survey

Advanced Medical Isotope (OTCMKTS:RDGL) and Rand Capital (NASDAQ:RAND) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability.

Earnings & Valuation

This table compares Advanced Medical Isotope and Rand Capital”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Isotope	$30,000.00	1,364.00	-$2.91 million	N/A	N/A
Rand Capital	-$5.79 million	-7.11	$8.83 million	($4.20)	-3.30

Rand Capital has lower revenue, but higher earnings than Advanced Medical Isotope.

Analyst Ratings

This is a breakdown of recent ratings for Advanced Medical Isotope and Rand Capital, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Isotope	0	0	0	0	0.00
Rand Capital	1	0	0	0	1.00

Volatility & Risk

Advanced Medical Isotope has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, Rand Capital has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500.

Profitability

This table compares Advanced Medical Isotope and Rand Capital’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Advanced Medical Isotope	-6,401.92%	N/A	-139.36%
Rand Capital	-90.42%	6.97%	6.47%

Summary

Rand Capital beats Advanced Medical Isotope on 5 of the 8 factors compared between the two stocks.

About Advanced Medical Isotope

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

About Rand Capital

Rand Capital Corporation is a business development company specializing in subordinated debt with warrants or preferred equity and venture capital investments. Within private equity, the firm specializing in capital growth and lower middle market investments. Within venture capital, it specializing in early to late-stage private businesses. It does not prefer to invest in real estate sector. It prefers to invest in software, professional services, manufacturing, consumer, healthcare, automotive and public d stocks. It prefers to invest in East or Midwest U.S. operations sectors. It typically invests between $0.75 million and $5 million with initial target size of $1.5 million. It seeks to invest in companies having more than $2 million in revenue or having excess of $1.5 million and up to $5 million in EBITDA. It prefers to be a minority stake and seeks to take a Board seat in its portfolio companies. It typically holds its investments for a period up to five years.